416 related articles for article (PubMed ID: 23589547)
21. [Targeted based therapies in metastatic breast cancer: future evolution].
Belmondo L; Montana M; Curti C; Crozet M; Rathelot P; Penot-Ragon C; Vanelle P
Therapie; 2012; 67(6):491-503. PubMed ID: 23249575
[TBL] [Abstract][Full Text] [Related]
22. [Desperately seeking targets].
Jordan B
Med Sci (Paris); 2015 Feb; 31(2):214-7. PubMed ID: 25744270
[TBL] [Abstract][Full Text] [Related]
23. Functional drug-gene interactions in lung cancer.
Smida M; Nijman SM
Expert Rev Mol Diagn; 2012 Apr; 12(3):291-302. PubMed ID: 22468819
[TBL] [Abstract][Full Text] [Related]
24. Personalized-medicine trials on the rise.
Benowitz S
J Natl Cancer Inst; 2012 Oct; 104(19):1425-6. PubMed ID: 23008496
[No Abstract] [Full Text] [Related]
25. [Biological network modelling and precision medicine in oncology].
Calzone L; Kuperstein I; Cohen D; Grieco L; Bonnet E; Servant N; Hupé P; Zinovyev A; Barillot E
Bull Cancer; 2014 Jun; 101 Suppl 1():S18-21. PubMed ID: 24966078
[TBL] [Abstract][Full Text] [Related]
26. Genetic alterations and personalized medicine in melanoma: progress and future prospects.
Griewank KG; Scolyer RA; Thompson JF; Flaherty KT; Schadendorf D; Murali R
J Natl Cancer Inst; 2014 Feb; 106(2):djt435. PubMed ID: 24511108
[TBL] [Abstract][Full Text] [Related]
27. Genomic medicine frontier in human solid tumors: prospects and challenges.
Dienstmann R; Rodon J; Barretina J; Tabernero J
J Clin Oncol; 2013 May; 31(15):1874-84. PubMed ID: 23589551
[TBL] [Abstract][Full Text] [Related]
28. Recent advances in the treatment of advanced renal cell carcinoma: towards multidisciplinary personalized care.
Bex A; Gore M; Mulders P; Sternberg CN
BJU Int; 2012 Nov; 110(9):1289-300. PubMed ID: 22624610
[TBL] [Abstract][Full Text] [Related]
29. The genetic complexity of common cancers and the promise of personalized medicine: is there any hope?
Arnedos M; Vielh P; Soria JC; Andre F
J Pathol; 2014 Jan; 232(2):274-82. PubMed ID: 24114621
[TBL] [Abstract][Full Text] [Related]
30. Precision medicine in pediatric oncology.
Forrest SJ; Geoerger B; Janeway KA
Curr Opin Pediatr; 2018 Feb; 30(1):17-24. PubMed ID: 29189430
[TBL] [Abstract][Full Text] [Related]
31. Impact of tumor sequencing on the use of anticancer drugs.
Thomas F; Desmedt C; Aftimos P; Awada A
Curr Opin Oncol; 2014 May; 26(3):347-56. PubMed ID: 24709974
[TBL] [Abstract][Full Text] [Related]
32. Recent developments and future perspectives of personalized oncology.
Grüllich C; von Kalle C
Onkologie; 2012; 35 Suppl 1():4-7. PubMed ID: 22286581
[TBL] [Abstract][Full Text] [Related]
33. Array-based pharmacogenomics of molecular-targeted therapies in oncology.
Sanoudou D; Mountzios G; Arvanitis DA; Pectasides D
Pharmacogenomics J; 2012 Jun; 12(3):185-96. PubMed ID: 22249357
[TBL] [Abstract][Full Text] [Related]
34. Breast cancer management: opportunities and barriers to an individualized approach.
Perez EA
Oncologist; 2011; 16 Suppl 1():20-2. PubMed ID: 21278437
[TBL] [Abstract][Full Text] [Related]
35. Targeting tyrosine kinases in cancer: the converging roles of cytopathology and molecular pathology in the era of genomic medicine.
Dumur CI; Idowu MO; Powers CN
Cancer Cytopathol; 2013 Feb; 121(2):61-71. PubMed ID: 22887782
[TBL] [Abstract][Full Text] [Related]
36. Translating basic research in cancer patient care.
Maugeri-Saccà M; De Maria R
Ann Ist Super Sanita; 2011; 47(1):64-71. PubMed ID: 21430342
[TBL] [Abstract][Full Text] [Related]
37. Integration of host-related signatures with cancer cell-derived predictors for the optimal management of anticancer chemotherapy.
Zitvogel L; Kepp O; Aymeric L; Ma Y; Locher C; Delahaye NF; André F; Kroemer G
Cancer Res; 2010 Dec; 70(23):9538-43. PubMed ID: 21098713
[TBL] [Abstract][Full Text] [Related]
38. Implementing precision medicine initiatives in the clinic: a new paradigm in drug development.
Hollebecque A; Massard C; Soria JC
Curr Opin Oncol; 2014 May; 26(3):340-6. PubMed ID: 24709975
[TBL] [Abstract][Full Text] [Related]
39. Surrogate markers for targeted therapy-based treatment activity and efficacy.
Bianchini G; Gianni L
J Natl Cancer Inst Monogr; 2011; 2011(43):91-4. PubMed ID: 22043050
[TBL] [Abstract][Full Text] [Related]
40. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
